(PharmaNewsWire.Com, December 23, 2017 ) The Europe Intrauterine devices (IUD’S) Market was worth $ 322 million in 2016 and estimated to reach $ 411 million by the end of 2021 with a growing potential of 5.00 %.
Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long time period. IUD’S are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device which is made of flexible plastic along with a copper wire wrapped around its stem and is a reliable and safe method of sterilization for women. It is injected into the uterus, and their primary aim is to inhibit the fertilization of the egg by causing changes, such as toxicity or thickening of the cervical mucus, thus inhibiting fertilization by a sperm. Mirena, Skyla and Paragard are some of the prominent brands available in the market. Growing incidence of unwanted pregnancies are accomplishing popularity, as intrauterine devices helps to limit the health care expenditure on abortions.
Europe intrauterine Device market is mainly driven by the factors such as Advancement in technical innovations, increasing prevalence of STD’S (Sexually transmitted diseases), instant health benefits other than birth control, increasing government initiatives to prevent unwanted abortions and pregnancies. The factors that hinder the growth of the market are Infertility issues, Economic constraints, and Limited access to contraception.
Market Segmentation
By Product Type • Hormonal Intrauterine Devices • Copper Intrauterine Devices
The Europe intrauterine Devices market is broadly categorized based on product type into Hormonal intrauterine device and Copper intrauterine device. The largest share in the market is held by Hormonal IUD’S. Since, they have less risks compared to non-hormonal IUD’S.
Key players influencing the Europe intrauterine devices market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc, Pfizer.
About Market Data Forecast: The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
